Object. Spinal cavernomas are rare, but can cause significant neurological deficits due to mass effect and extralesional hemorrhage. The authors present their results of microsurgical treatment of 14 consecutive patients with spinal cavernoma, and review the literature.
S
pinal cavernomas are a rare pathology. While the incidence of spinal cavernomas is unknown, they represent 5% to 12% of spinal vascular abnormalities. 16 In addition, the natural history of spinal cavernomas remains undefined. Progressive myelopathy caused by typical microhemorrhages and perifocal gliosis probably explains the neurological decline of affected patients. 19 Risk of profuse hemorrhage ranges between 1.4% and 4.5% per patient per year, increasing to 66% per patient per year in patients with a previous history of hemorrhage. 61, 81 Due to low tolerance of the medulla to a mass lesion, patients frequently present with progressive focal sensorimotor deficits often combined with intensive radicular or central pain. 39 Surgical removal of a symptomatic cavernoma is therefore warranted to prevent further neurological deterioration, but must be weighed against the potential risks of surgery. According to the literature, 59% to 66% of patients with spinal cavernomas improve after surgery, and only 6% have permanent disabling neurological deficits. 77, 81 Pain relief is satisfactory immediately after surgery, but during long-term follow-up pain recurs in as many as 50% of patients. 39 In general, the literature on spinal cavernomas is scarce, and is limited to small retrospective series of patients. In this study we report our experience of microsurgical treatment of 14 consecutive patients with spinal cavernomas, supplemented with a literature review.
Methods

Study Population
Of 376 consecutive patients with cavernomas of the CNS treated at Helsinki University Central Hospital (a catchment area close to 2 million inhabitants) between January 1980 and June 2009, 14 (4%) had a spinal cav-ernoma. We examined the patient files and images retrospectively. The study protocol was approved by the local ethics committee.
Imaging Procedure
In all patients, spinal axis MR imaging was performed using standard T1-and T2-weighted sequences. In 9 patients (64%), cavernomas were intramedullary ( Fig.  1) , whereas 4 patients (29%) had an extradural lesion (Fig.  2) , and 1 had an intradural extramedullary cavernoma with an isolated intramedullary hemorrhage ( Fig. 3 ; Table  1 ). On MR imaging, cavernomas had a typical heterogeneous core surrounded by a hemosiderotic rim, as well as perifocal edema when in an intramedullary location. One patient (Case 4) had an intradural extramedullary cavernoma, which caused intramedullary hemorrhage. 41 Six patients (43%) had cervical cavernomas, 7 (50%) thoracic cavernomas, and 1 (7%) a conus medullaris cavernoma. None of the patients had multiple lesions. Five patients had cavernomas located at the midline, 7 on the left side, and 2 on the right side. The median size of intramedullary cavernomas was 7 mm (range 5-10 mm), and the median size of extramedullary cavernomas was 15 mm (range 10-40 mm).
Surgical Treatment
Indications for microsurgical removal of a spinal cavernoma were progressive neurological deterioration in 12 patients (86%) and prevention of bleeding and consequent neurological decline in the remaining 2 patients (14%). Three patients (21%) with acute onset of the disease underwent operations within 24 hours of symptom onset. Two of the patients with cervical cavernoma developed severe tetraparesis, and 1 with a lower thoracic cavernoma developed paraparesis, which worsened quickly to complete paralysis.
Nine patients (64%) underwent hemilaminectomy and 5 (36%) laminectomy. In cases of hemilaminectomy, the exposure was performed on the appropriate side to minimize distance to the lesion. In patients with epidural cavernoma, a lesion was revealed in the epidural space immediately after removal of the ligamentum flavum. Intradural cavernomas were approached by sharp incision of the dura and arachnoid and exposure of the affected medullary segment. Myelotomy was performed at the discolored or bulging medullary surface suggesting a cavernoma or where the lesion was visible. When the location of the intramedullary cavernoma was indistinguishable on the surface, a gentle longitudinal incision of the pia and medulla was performed at the site of the suggested lesion until the pathology was reached. No neurophysiological monitoring was performed because either this technique was not available, or the surgeon preferred to operate without it. In cases of a hemorrhage from a cavernoma, the hematoma was aspirated first to decompress the medulla, and thereafter the cavernoma was removed in a piecemeal manner to minimize distortion of the normal neural tissue. Accurate hemostasis was performed by low-voltage bipolar coagulation and local hemostats. The dura was closed in a watertight manner to prevent CSF leakage. After a median of 5 days (range 3-13 days) at our department, patients were transferred to referring hospitals for further rehabilitation. 
Postoperative Course
Immediately after surgery, 8 patients (57%) showed improvement of symptoms, while 2 (14%) remained the same and 4 (29%) complained of worsening of symptoms; 2 of these patients experienced new neurological deficits. At discharge, 10 patients (71%) experienced improvement of neurological status, 3 (21%) had worsening of symptoms or some new deficits, and 1 patient remained the same.
Four patients (29%) underwent reoperation. In 2 of these patients, the cavernoma was not found during the first operation, 1 patient had a regrowth of the removed cavernoma, and 1 patient had a huge cavernoma that caused vertebral fracture. The last patient underwent 3 posterior decompressions because of progressive growth of the lesion (laminectomy, followed by another laminectomy and postoperative hematoma evacuation) and transpedicular fixation and biopsy of the lesion, followed by radiotherapy, ultimately with a good outcome.
Results
Basic characteristics of the patients are presented in Table 2 . Median age at presentation was 45 years (range 20-57 years), with an equal male/female ratio (7 each). Median duration of symptoms before admission to our department was 12 months (range 0.1-168 months). Patients suffered from sensorimotor paresis, radicular pain, or neurogenic micturition disorders in different combinations or separately. Six patients had cervical region cavernomas. Of these 6 patients, 2 suffered from severe tetraparesis; 2 presented with Brown-Séquard syndrome with ipsilateral paresis, contralateral pain, and temperature loss below the lesion; and 2 experienced upper extremity sensorimotor deficits accompanied by severe radicular pain. In this group, 2 patients suffered from bladder disturbances, with one of them being severe.
Eight patients presented with thoracolumbar region cavernomas (7 thoracic and 1 conus medullaris lesion). Of these 8 patients, 4 presented with motor paraparesis of the lower extremities combined with bladder dysfunction and numbness. Others suffered from drug-resistant radicular pain, numbness, and motor paresis of one of the lower extremities. Micturition disorders occurred in 3 patients.
Three patients (21%) presented with acute onset of symptoms, with rapid neurological decline indicating emergency surgical treatment. Five patients (36%) had gradual progression of neurological deficits in the month preceding surgery and 6 patients (46%) experienced slow progression for more than 1 year. In 2 patients (14%) symptoms improved before admission to our hospital, but surgery was performed to prevent hemorrhage and potential further neurological decline. Hemorrhage occurred in 7 patients (50%) before surgery. Four of these patients experienced acute neurological deterioration, warranting further investigations immediately after onset. However, 2 patients with hemorrhage did not have acute onset of the disease, which deteriorated slowly over the course of several weeks. On MR imaging, signs of a recent hemorrhage were found. One patient had symptomatic rebleeding after 14 years of observation; he was intact after the first hemorrhage, which was treated conservatively, but his condition deteriorated acutely due to rehemorrhage, indicating a need to surgically remove the lesion.
Postoperative Course
Patients were followed up for a median of 3 years (range 1-10 years). At the last follow-up, 8 patients (57%) experienced further improvement of their symptoms since discharge, with 2 of them (14%) recovering fully. Five patients (36%) had the same neurological disorders as at discharge. One patient's condition (7%) was worse than it was preoperatively. In 7 patients (50%), their deficits did not affect everyday life, and 7 (50%) had some mild limitations. No patient experienced severe disability or died (Table 3) .
No significant difference in outcome was observed between cervical and thoracolumbar cavernomas. The extramedullary location proved to be better and safer regarding outcome: 4 (80%) of the 5 patients demonstrated further improvement of the symptoms, whereas only 4 (50%) of 8 with an intramedullary lesion did the same. Five (71%) of the 7 patients with a history of hemorrhage had some disability at follow-up, whereas only 1 (14%) of 7 nonhemorrhagic patients had the same. Aggressive behavior of the disease preoperatively accompanied by rapid neurological deterioration was detrimental regarding outcome: 5 of 8 patients with fast progression within only a few weeks (63%) had a worse outcome.
Recovery From Sensorimotor Paresis
After surgery, all patients underwent active rehabilitation at referring hospitals. Twelve patients (86%) showed significant recovery of sensorimotor paresis at the last follow-up as compared with their preoperative state. Five of these patients were able to walk independently and the remaining 7 were able to walk with a cane or a rolling walker. Cases 1 and 11 (Table 2) experienced some new permanent sensorimotor deficits after surgery that impaired their mobility and ability to work, but Case 11 improved markedly during follow-up.
Recovery From Pain
Ten (71%) of the 14 patients suffered from radicular pain before surgery. During follow-up, 9 (90%) of these 10 patients showed significant pain relief and did not complain of any disturbing pain. Only 1 patient (10%) developed permanent painful allodynia in her hand.
Recovery From Bladder Dysfunction
Micturition disorders were registered in 6 patients (43%) at follow-up, with 5 of these existing before surgery. No patient experienced significant improvement of micturition after surgery. Patients suffered from urinary incontinence, increased residual urine volume, and loss of voluntary emptying of the bladder, requiring regular bladder autocatheterization daily. Frequent urinary tract infections were common, often requiring oral antibiotic administration. Two patients developed hyperactive bladder disorder with increased urinary frequency of up to 12 times a day accompanied by urge incontinence. In 1 of these patients, this disorder was not present before removal of the cavernoma. One patient was treated with anticholinergics, followed by sacral epidural stimulation performed by a urologist without success.
Discussion
Based on our series, spinal cavernomas can cause marked neurological deterioration due to mass effect and/ or hemorrhage. In fact, 21% of our patients developed acute severe tetraparesis or paraparesis within a time span of a few hours, requiring immediate treatment. In the literature, acute deterioration was reported in as many as 38% of patients, and 70% of these were related to hemorrhage. 19, 43 Even without acute onset, cavernomas affecting the spinal cord can cause neurological deterioration by chronic microhemorrhages into the surrounding tissue, with subsequent gliosis and progressive myelopathy. Although observation is reported to be an alternative to active surgical treatment, 38 accumulating data in the literature confirm the dynamic nature of spinal cavernomas, which have a tendency toward clinical deterioration, often warranting operative treatment. 14, 36, 39, 41, 43, 47, 54, 55, 62, 81 Even considering that the annual bleeding rate in spinal cavernomas is relatively low, 61, 81 preventive removals of cavernomas before hemorrhage is more beneficial for patients than surgery after bleeding. Postoperative complications are usually mild and most tend to resolve with time. Immediately after surgery, one-third of our patients demonstrated worsening of neurological status, with ap- pearance of new deficits in some. However, at the 3-year follow-up, only 1 patient (7%) complained of significant surgery-related deficit, and the others had improved or symptoms had completely resolved.
Tumor Location
Included among the literature and the present series are a total of 451 patients with spinal cavernomas; 383 (85%) were intramedullary (Tables 4 and 5) . Available follow-up data on patients undergoing operations were found in 351 cases. Patients with intramedullary and extramedullary lesions showed improvement in 62% and 90% of cases, respectively, which is in accordance with our patient series in which the corresponding rates were 44% and 80%, respectively (Table 6 ). Persistent worsening of neurological status registered at the long-term follow-up occurs rarely in both groups, but was more frequent for the intramedullary location (9% in intramedullary 8, 11, 13, 16, 17, 19, 36, 43, 48, 75, 77, 79, 81 vs 2% in extradural 33 ) both in the literature and in our series.
The compression of rootlets appears to be better tolerated than myelopathy caused by intraaxial cavernoma affecting the gray and white matter of the spinal cord from inside. Furthermore, cavernoma microhemorrhages and subsequent myelopathy aggravated by surgical manipulations explain the slower recovery process after intramedullary cavernoma removal.
It is unclear whether extradural cavernomas have different growing patterns or hemorrhage rates than intramedullary lesions. Interestingly, extramedullary cavernomas were characterized by fast progression of neurological status in 80% of cases, in contrast to only 45% for intramedullary cavernomas. However, only 1 of 5 patients with extramedullary cavernomas presented with a hemorrhage. Thus, one of the reasons may be a faster growing pattern of the extramedullary lesions.
In as many as 77% of patients in the literature, cavernomas were located in the thoracic region. 19, 43 Cervical location was less frequent and lumbar cavernomas were very rare. In our patients, thoracic cavernomas were less common, constituting 50% of cases, whereas cervical cavernomas occurred in 43%. None our patients had a cavernoma involving the cauda equina. In the literature, only 14 cases of caudal cavernomas (4%) have been published. 21, 57, 58, 74 
Patient Prognosis
In our series, the follow-up period was a median of 36 months, consistent with rates in the literature (Tables  4 and 5 ). Extramedullary location and slower neurological deterioration appeared to be beneficial regarding functional outcome. Most of our patients (93%) improved or remained stable, in accordance with previous reports. 36 Age, sex, and severity or duration of symptoms before surgery did not correlate with outcome in our study. However, in the literature, shorter duration of symptoms before surgery was related to better outcome. 80 Hemorrhage had a strong association with a worse outcome; 5 of our 6 patients with motor disability at follow-up suffered a hemorrhage before treatment, whereas 6 of 7 nonhemorrhagic patients demonstrated no disability. Furthermore, rapid progression of neurological deficits led to a worse postoperative outcome in 71% of our patients, whereas slow deterioration led to an unfavorable outcome in only 33%.
In previous reports, scrupulous depiction of the persistent neurological status at the long-term follow-up was uncommon; status was most frequently assessed as worse, same, and improved (Tables 4 and 5 ). In our series, we analyzed recovery from sensorimotor deficits, pain, and bladder disorders separately.
Sensorimotor Deficits
Recovery potential from sensorimotor deficit appears to be the most prominent given that most of the patients (86%) experienced significant improvement in mobility and all patients were able to walk with or without aid. However, 2 of our patients demonstrated progressive decline of motor function after surgery. One of them was operated on 3 times because the lesion could not be identified at the first attempt and the second surgery was limited to biopsy only; at the third operation the cavernoma was removed. After the last surgery, the patient could walk with some spasticity. The other patient with a lower cervical lesion underwent an operation 1 year after onset of symptoms, and before the surgery her deficits had improved completely. After surgery, she developed tetraparesis, which resolved significantly, but her left hand remained weaker and her legs were atactic. 
Radicular Pain
Our patients demonstrated good recovery from pain in 90% of cases. No difference existed between extra-and intramedullary cavernomas regarding pain relief. Only 1 patient complained of pain, which appeared after removal of the cavernoma and gradually worsened, with only partial effect after medication (allodynia). In our series, there was no pain recurrence at follow-up among those who presented with pain before surgery, in contrast to findings in the literature. 39 
Bladder Dysfunction
Although bladder disorders were present in one-third of our patients, outcome data on bladder function after surgery are lacking. Few reports specifically mention recovery of bladder function. 4, 21, 42, 51, 74, 79 Naturally, this defect is important clinically and socially, especially in young adults. Micturition disorders remained almost unchanged in all of our patients presenting with a bladder dysfunction preoperatively. Furthermore, 1 patient developed micturition disorders after surgery. Typically, at disease onset, patients presented with atonic bladder with urine retention, requiring catheterization preoperatively. During the postoperative period, 2 patients developed hyperactivity and dyssynergy of the bladder, with high daytime urinary frequency and urge incontinence.
Conclusions
The finding in our series combined with the literature review show that spinal cavernomas can cause severe neu- rological deterioration due to low tolerance of the spinal cord to mass effect with progressive myelopathy. When aggravated by extralesional massive hemorrhage, neurological decline is usually acute and requires immediate treatment. Microsurgical removal of a cavernoma is effective and safe, improving neurological deficits by mass removal and preventing further hemorrhage, thereby arresting progressive myelopathy. Sensorimotor deficits and pain improved postoperatively at a high rate, whereas bladder dysfunction remained essentially unchanged, causing social discomfort to patients.
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